Nexstim

Focus: Nexstim is a Finnish biotech specializing in Transcranial Magnetic Stimulation (TMS) technology for neurological and neurosurgical applications. The company operates at a modest scale with a single active job opening, suggesting a small, focused organization.

Unknown

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Nexstim

AI assessmentNot Hiring

No open roles listed right now. Follow Nexstim to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

6 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Nexstim NBS guided active rTMS

Ischemic Stroke

N/A

Clinical Trials (1)

NCT03010462Electric Field Navigated 1hz Rtms for Post-stroke Motor Recovery Trial

N/A

Help build intelligence for Nexstim

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to work on differentiated TMS technology in underexplored indications including stroke recovery and brain tumor surgery
Early-stage company likely offers high visibility to executive leadership and broad cross-functional exposure
Focused pipeline with 6 active programs allows meaningful individual impact on clinical strategy

Watch Out For

Extremely limited hiring activity (1 active role) suggests either early stage or financially constrained operations with minimal growth trajectory
No marketed products or revenue disclosed indicates pre-commercial stage with extended timeline to value realization and cash burn risk
Lack of publicly available financials, funding data, or employee count raises transparency concerns about company stability and growth capacity

Generated by Claude from Nexstim's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Navigated TMS examination

Ischemic Stroke

N/A

Clinical Trials (1)

NCT01005394Navigated Transcranial Magnetic Stimulation in Monitoring Stroke Recovery

N/A

NBS-guided rTMS

Stroke

N/A

Clinical Trials (1)

NCT02089464Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial

N/A